Multiple Myeloma Patient Committed to Persevering

Russ Horn went to work every day as a firefighter for almost 30 years. But now he has a new job—one that takes the same courage, hard work, and perseverance required in his last role. In 2014, Horn, then 50, was diagnosed with multiple myeloma—a cancer of plasma cells—after a minor slip at work sent … Continued

Myeloma Study Makes the Case for a New Standard for Predicting Long-Term Outcome

As new treatments for multiple myeloma have extended patient survival—from an average of three years to more than 10 in some cases—physicians and researchers face a new challenge: how to predict a drug’s long-term effectiveness? How to tell, early on, whether one drug is likely to extend patients’ lives more than another? At Dana-Farber’s Jerome Lipper … Continued

Immunotherapies Producing Dramatic Results in Multiple Myeloma

Advances against multiple myeloma have come at an especially rapid pace, with 10 new therapies approved in just the last 10 years. As a group, their impact “is greater than anything we’ve seen in myeloma,” says Nikhil Munshi, MD, director of Basic and Correlative Science at Dana-Farber’s Jerome Lipper Center for Multiple Myeloma.

CAR T-Cell Clinical Trial Has Multiple Myeloma Patient Back On Her Feet

A year ago, Kelly Lamphere’s multiple myeloma was not responding to treatment, and her legs were so weakened by the cancer in her bones that she relied on a wheelchair and a walker. Today, because of CAR T-cell therapy, Lamphere’s disease is under control—and she can walk unaided again.

From Teacher to Cancer Caregiver – and Coach

“A caregiver and a patient are a team, like a coach and a quarterback,” says caregiver Deb Osborne. “You do a lot of work strategizing together beforehand, and then as the coach you send your quarterback into the action.

CAR T-Cell Therapy: Is It Right For You?

CAR T-cell therapy is a cancer treatment in which a patient’s immune system T cells are genetically modified to mount a more effective attack on cancer. As of May 2018, CAR T-cell therapy has been approved by the U.S. Food and Drug Administration as standard therapy for some adult patients with aggressive non-Hodgkin lymphoma that has relapsed after … Continued

Multiple Myeloma: Optimizing Quality of Life for Survivors

Thanks to major advances in treatment in recent years, patients diagnosed with multiple myeloma today have a much greater life expectancy, even though the blood cancer isn’t curable. It’s possible to think of myeloma – a malignancy affecting antibody-producing immune cells – as a chronic disease with which some individuals can live for many years. … Continued

What Care Do I Need After a Stem Cell Transplant?

A stem cell transplant can be a lifesaving treatment for patients with leukemia, lymphoma, multiple myeloma, or certain blood-related disorders. In many cases, however, transplants increase patients’ risk for an array of long-term health problems, often caused by the high doses of chemotherapy and/or radiation therapy used prior to the transplant. Dana-Farber’s Adult Stem Cell Survivorship … Continued

The Latest Advances Against Hematologic Cancers

Treatment of blood-related, or hematologic, cancers is seizing on insights into the basic genetic wiring of cancer cells and the body’s system for finding and attacking those cells. Research presentations at the annual American Society of Hematology (ASH) meeting in December gave evidence of how broad, and rapid, the progress is. Targeted therapies, new combinations … Continued

What’s New in Multiple Myeloma? [Webchat]

In a recent Facebook Live webchat, Jacob Laubach, MD, MPP, Clinical Director of the Jerome Lipper Multiple Myeloma Center, discussed the different ways that patients can be treated with multiple myeloma, as well as exciting avenues of treatment, such as combination therapy.

Signs and Symptoms of Multiple Myeloma

Multiple myeloma, also called Kahler’s disease, is a type of cancer that begins in plasma cells – white blood cells that produce antibodies. Plasma cells usually work in the body’s immune defense system and help produce antibodies. In cases of multiple myeloma, however, too many plasma cells build up in the bone marrow and form tumors in many … Continued

Cancer Conversations Podcast – Episode #4: The Latest Research in Multiple Myeloma and Leukemia

With new research in immunotherapy and targeted therapy, treatment options for blood cancer patients are rapidly expanding. Combination therapies have also caused much excitement among researchers and physicians, and ongoing clinical trials are continuing to look at new strategies that use multiple drugs for fighting these diseases. In this Cancer Conversations podcast episode, Irene Ghobrial, … Continued

Remembering My Father’s Journey with Multiple Myeloma

By Elise Renner There’s a 1-in-12 chance that this is the month yours or your loved one’s cancer is recognized—odds better than the survival rates for some of these diseases. Some months, like October, boast big names like breast cancer. Others, like September, are crowded with lesser-known branches of the disease. “Cancer apparel,” including ribbons … Continued

Tom Brokaw: What It Means to Have Cancer

The world is divided between those who are sympathetic to their friends and family who have cancer and those who have cancer and are empathetic with each other, says Tom Brokaw, the former “NBC Nightly News” anchor. Brokaw, who was diagnosed with multiple myeloma in August 2013, shares his cancer story in the video below. … Continued